Procter & Gamble Co.'s Proxy Fight: What Investors Need to Know
Procter & Gamble (NYSE: PG) is facing an unusual shareholder challenge. Activist investor Trian Fund, after being turned down in talks with the consumer products giant's management, is going around the executive team and petitioning support directly from shareholders to win a seat on P&G's board of directors.
The move makes P&G the biggest company to ever face a proxy fight, according to The Wall Street Journal. Let's look at what the battle means for investors.
Image source: P&G.
Source: Fool.com
Procter & Gamble Co. Stock
€152.28
-0.510%
With 29 Buy predictions and not a single Sell prediction Procter & Gamble Co. is an absolute favorite of our community.
As a result the target price of 160 € shows a slightly positive potential of 5.07% compared to the current price of 152.28 € for Procter & Gamble Co..
